109614 ⎘
dsDNA viruses; Details; Adenoviridae New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
ONCOLYTIC ADENOVIRAL VECTOR AND METHODS OF USE
#2PHARMACEUTICAL COMPOSITION FOR RESISTING INFECTION WITH SARS-COV-2 OR MUTANT THEREOF, AND COMBINED DRUG THEREOF
#3IMMUNE-CLOAKING ANTITUMOR ADENOVIRUS
#4ADENOVIRAL VECTOR-BASED VACCINE FOR EMERGING VIRUSES
#5TUMOR-SELECTIVE E1A AND E1B MUTANTS
#6ADENOVIRAL GENE THERAPY VECTORS
#7ANTI-GUCY2C VACCINES AND VACCINATION
#8MUTANT E1A ANTAGONIZING UBIQUITINATION-MEDIATED DEGRADATION AND ITS USE IN THE PREPARATION OF POTENTIATED ONCOLYTIC ADENOVIRUSES AND IMMUNE POTENTIATORS
#9METHODS FOR PROCESSING AND ANALYZING VIRUS CAPSID PROTEINS
#10VIRUS ENCODING TRANSGENES TO COMPLEMENT CELLULAR THERAPY
#11ADENOVIRUS CONSTRUCTS AND METHODS OF USE
#12MULTIPLEXED-TARGETED ADENOVIRUS VECTORS AND THEIR USE
#13RECOMBINANT ADENOVIRUS VACCINE FOR AFRICAN SWINE FEVER AND METHOD FOR CONSTRUCTING SAME
#14VIRAL GENE THERAPY AS TREATMENT FOR CHOLESTEROL STORAGE DISEASE OR DISORDER
#15PRODUCTION AND PURIFICATION OF COVALENTLY SURFACE MODIFIED ADENO-ASSOCIATED VIRUS
#16METHODS FOR PRODUCTION OF THERAPEUTIC IMMUNE CELLS HAVING ENHANCED METABOLIC FITNESS AND COMPOSITIONS THEREOF
#17METHODS OF PURIFYING ADENOVIRUS
#18An oncolytic virus vector coding for interleukin-7 (IL-7) polypeptide
#19ADENOVIRUSES AND METHODS FOR USING ADENOVIRUSES
#20IMMUNOEVASIVE ANTI-TUMOR ADENOVIRUS
#21Therapeutic pharmaceutical composition for bone and soft tissue tumors
#22ADENOVIRUS FOR TREATMENT OF CANCER
#23CHIMERIC BROAD-SPECTRUM ONCOLYTIC ADENOVIRUS WITH MULTIPLE MECHANISMS SYNERGIZING WITH AND ENHANCING EFFICACY OF IMMUNOTHERAPY, AND APPLICATION THEREOF IN TUMOR TREATMENT
#24ADENOVIRAL GENE THERAPY VECTORS
#25Desmoglein 2 (DSG2) Binding Proteins and Uses Therefor
#26Adenoviral vector not including replication competent adenovirus, and use thereof
#27RECOMBINANT ONCOLYTIC VIRUSES, SURFACE-ENGINEERED DELIVERY SYSTEMS AND RELATED METHODS
#28GORILLA ADENOVIRUS NUCLEIC ACID- AND AMINO ACID-SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREOF
#29REPLICATION-DEFICIENT ADENOVIRUS
#30ENGINEERED ADENOVIRUS VECTORS AND USES THEREOF
#31CELL LINES FOR RECOMBINANT AAV PRODUCTION AND AAV-IMPLEMENTED PROTEIN PRODUCTION
#32Tumor-selective E1a and E1b mutants
#33RECOMBINANT ADENOVIRUS GENOME HAVING A SYNTHETIC TRANSCRIPTIONAL UNIT AND TWO STEP TRANSCRIPTIONAL REGULATION AND AMPLIFICATION
#34HELPER PLASMID-BASED GUTLESS ADENOVIRUS PRODUCTION SYSTEM
#35Desmoglein 2 (DSG2) binding proteins and uses therefor
#36VECTORIZED ANTIBODIES AND USES THEREOF
#37GENE THERAPY
#38BIO-IMAGING PROBES AND METHODS FOR NON-INVASIVE DETECTION OF HUMAN UTERINE SARCOMAS
#39Tumor-selective E1A and E1B mutants
#40Viral gene therapy as treatment for cholesterol storage disease or disorder
#41Adenoviral Polypeptide IX Increases Adenoviral Gene Therapy Vector Productivity and Infectivity
#42Multivalent PD-L1 binding compounds for treating cancer
#43Desmoglein 2 (DSG2) binding proteins and uses therefor
#44Oncolytic adenoviral vector and methods of use
#45Hexon protein hypervariable region gene sequence of adenovirus and its application
#46Cell line for producing adenovirus and method of preparing the same
#47Tropism-Modified Recombinant Viral Vectors and Uses Thereof for the Targeted Introduction of Genetic Material into Human Cells
#48Adenoviral Polypeptide IX Increases Adenoviral Gene Therapy Vector Productivity and Infectivity
#49HPV vaccines
#50Tumor-selective E1a and E1b mutants
#51Hexon protein hypervariable region gene sequence of adenovirus and its application
#52Desmoglein 2 (DSG2) binding proteins and uses therefor
#53VIRAL GENE THERAPY AS TREATMENT FOR CHOLESTEROL STORAGE DISEASE OR DISORDER
#54CANCER INITIATING CELL AND USE THEREOF
#55Multitargeting onocolytic adenovirus, methods of use, and methods of making
#56Desmoglein 2 (DSG2) binding proteins and uses therefor
#57SIMIAN ADENOVIRUS NUCLEIC ACID AND AMINO ACID SEQUENCES, VECTORS CONTAINING SAME, AND METHODS OF USE
#58Modified Adenovirus Hexon Protein and Uses Thereof
#59Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
#60Penton-mutated, integrin-retargeted adenovirus vectors with reduced toxicity and their use
#61TUMOR-SELECTIVE E1A AND E1B MUTANTS
#62SIMIAN ADENOVIRUS NUCLEIC ACID AND AMINO ACID SEQUENCES, VECTORS CONTAINING SAME, AND METHODS OF USE
#63Desmoglein 2 (DSG2) Binding Proteins and Uses Therefor
#64Immunotherapy targeting intracellular pathogens
#65Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
#66Expression vector and methods of producing high levels of proteins
#67Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
#68Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
#69IMMUNOTHERAPY TARGETING INTRACELLULAR PATHOGENS
#70Tumor selective E1a and E1b mutants
#71Expression vector and methods of producing high levels of proteins
#72Adipogenic Adenoviruses As A Biomarker For Disease
#73Anti-HMGA1 monoclonal antibodies, process for their preparation and their use for the quantitative determination of HMGA1
#74ANTIVIRAL ACTIVITY OF CIDOFOVIR AGAINST ONCOLYTIC VIRUSES
#75Method for transfer of molecular substances with prokaryotic nucleic acid-binding proteins
#76Method and kit for the detection of adenoviruses
#77Adipogenic adenoviruses as a biomarker for disease
#78Adipogenic adenoviruses as a biomarker for disease
#79Modified Adenovirus Hexon Protein and Uses Thereof
#80COMPOSITIONS FOR USE IN IDENTIFICATION OF ADENOVIRUSES
#81Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
#82Adipogenic adenoviruses as a biomarker for disease
#83Method for transfer of molecular substances with prokaryotic nucleic acid-binding proteins
#84Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use